Managing uncertainty: Healthcare professionals' meanings regarding the HPV vaccine

International Journal of Behavioral Medicine

Volumn 21, Issue 1, 2014, Pages 29-36

  Todorova, Irina ^a   Alexandrova Karamanova, Anna ^b   Panayotova, Yulia ^b   Dimitrova, Elitsa ^c   Kotzeva, Tatyana ^d  

^a NORTHEASTERN UNIVERSITY   (United States)

^b Health Psychology Research Center   (Bulgaria)

^c BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^d BURGAS FREE UNIVERSITY   (Bulgaria)

Author keywords

Bulgaria; Eastern Europe; Healthcare Providers; HPV vaccine; Narrative Analysis

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; ATTITUDE TO HEALTH; BULGARIA; FEMALE; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HUMAN; LANGUAGE; PAPILLOMAVIRUS INFECTION; PARENT; PERCEPTION; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; UNCERTAINTY; UTERINE CERVIX TUMOR; VACCINATION; VIROLOGY;

ATTITUDE OF HEALTH PERSONNEL; BULGARIA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; LANGUAGE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PERCEPTION; QUALITATIVE RESEARCH; UNCERTAINTY; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84899424608     PISSN: 10705503     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12529-013-9343-9     Document Type: Article

References (47)

1. Wailoo K, Livingston J, Aronowitz R. Vaccine time lines. In:Wailoo K, Livingston J, Aronowitz R, editors. Three shots at prevention: the HPV vaccine and the politics of medicine's simple solutions. Baltimore: Johns Hopkins University Press; 2010. p. xix-xxix.
2. Barroso LF, Wilkin T. Human papillomavirus vaccination in males: the state of the science. Curr Infect Dis Rep. 2011;13(2):175-81. doi: 10.1007/s11908-010-0163-7.
3. European Centre for Disease Prevention and Control. Guidance for the introduction of HPV vaccines in EU countries. 2008.
4. King LA, Lévy-Bruhl D, O'Flanagan D, Bacci S, Lopalco PL, Kudjawu Y, et al. Introduction of human papillomavirus (HPV) vaccination into national immunization schedules in Europe: results of the VENICE 2007 survey. Eurosurveillance. 2008;13(7-9):1-6.
5. American Academy of Pediatrics. HPV vaccine recommendations. Pediatrics. 2012;129(3):602-5.
6. Gottlieb SD. Manufactured uncertainty: the human papillomavirus (HPV) vaccine and the object multiple. US: ProQuest Information & Learning; 2011.
7. Newmann SJ, Garner EO. Social inequities along the cervical cancer continuum: a structured review. Cancer Causes and Control. 2005;16:63-70. (Pubitemid 40568852)
8. Tomljenovic L, Shaw CA. Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds? Ann Med. 2013;45(2):182-93.
9. Braun L, Phoun L. HPV vaccination campaigns: masking uncertainty, erasing complexity. In: Wailoo K, Livingston J, Epstein S, Aronowitz R, editors. Three shots at prevention: The HPV vaccine and the politics of medicine's simple solutions. Baltimore: Johns Hopkins University; 2010.
10. Tsu VD, Levin CE. Making the case for cervical cancer prevention: what about equity? Reprod Health Matters. 2008;16(32):104-16.
11. Farmer P. Dimensions of health disparities in infectious diseases: Key Note lecture. Centers for Population Health and Health Disparities Annual Meeting; May 1-2; Boston, MA2013.
12. Julius JM, Ramondeta L, Tipton KA, Lal LS, Schneider K, Smith JA. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer. Pharmacotherapy. 2011;31(3):280-97.
13. Casper MJ, Carpenter LM. Sex, drugs, and politics: the HPV vaccine for cervical cancer. Sociol Health Illn. 2008;30(6):886-9.
14. Charo RA. Politics, parents, and prophylaxis - mandating HPV vaccination in the United States. N Engl J Med. 2007;356(19):1905-8. (Pubitemid 46740299)
15. Javitt G, Berkowitz D, Gostin LO. Assessing mandatory HPV vaccination: who should call the shots? J Law Med Ethics. 2008;36(2):384.
16. Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low-average levels and large inequalities. PLOS Medicine. 2008;5(6):e132.
17. Huang CM. Human papillomavirus and vaccination. Mayo Clinic Proceedings. 2008;83(6):701.
18. Avramova L, Alexandrova A, Balabanova D, Bradley J, Panayotova Y, Todorova I. Cervical cancer screening in Bulgaria: psychosocial aspects and health systems dimensions. Sofia, Bulgaria: Health Psychology Research Center & Engender Health; 2005.
19. Todorova I, Baban A, Alexandrova-Karamanova A, Bradley J. Inequalities in cervical cancer screening in Eastern Europe: perspectives from Bulgaria and Romania. Int J Public Health. 2009;54:222-32.
20. Bonanni P, Levi M, Latham NB, Bechini A, Tiscione E, Lai P, et al. An overview on the implementation of HPV vaccination in Europe. Hum Vaccin. 2011;7(Suppl):128-35
21. Ministry of Health. (National program for primary prevention of cervical cancer in Bulgaria 2012-2016). Sofia, Bulgaria: Voted by Council of Ministers, Protokol #25, June 25th 2012.
22. Bartlett JA, Peterson JA. The uptake of human papillomavirus (HPV) vaccine among adolescent females in the United States: a review of the literature. J Sch Nurs. 2011;27(6):434-46.
23. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2-3):107-14. doi:10.1016/j.ypmed.2007.05.013. (Pubitemid 47348081)
24. Brewer NT, Gottlieb SL, Reiter PL, McRee A-L, Liddon N, Markowitz L, et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis. 2011;38(3):197-204. doi:10.1097/OLQ.0b013e3181f12dbf.
25. Dimitrova E, Panayotova Y, Alexandrova-Karamanova A, Todorova I. Doctors' and parents' perspectives on communication regarding HPV vaccination in Bulgaria. Health, Culture and the Human Body; 15-17 September 2012; Istanbul, Turkey2012.
26. Kessels SJM, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30(24):3546-56.
27. Trim K, Nagji N, Elit L, Roy K. Parental knowledge, attitudes, and behaviours towards human papillomavirus vaccination for their children: a systematic review from 2001 to 2011. Obstet Gynecol Int. 2012;2012:1-12. doi:10.1155/2012/921236.
28. Brownlie J, Howson A. 'Between the demands of truth and government': health practitioners, trust and immunisation work. Soc Sci Med. 2006;62(2):433-43. doi:10.1016/j.socscimed.2005.05.033. (Pubitemid 41735430)
29. Barnack JL, Reddy DM, Swain C. Predictors of parents' willingness to vaccinate for human papillomavirus and physicians' intentions to recommend the vaccine. Women's Health Issues. 2010;20(1):28-34.
30. Huey NL, Clark AD, Kluhsman BC, Lengerich EJ. HPV vaccine attitudes and practices among primary care providers in Appalachian Pennsylvania. Prev Chronic Dis. 2009;6(2):A49.
31. Ko EM, Missmer S, Johnson NR. Physician attitudes and practice toward human papillomavirus vaccination. J Low Genit Tract Dis. 2010;14(4):339-45.
32. Lutringer-Magnin D, Kalecinski J, Barone G, Leocmach Y, Regnier V, Jacquard AC, et al. Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing. Vaccine. 2011;29(32):5322-8.
33. Songthap A, Pitisuttithum P, Kaewkungwal J, Fungladda W, Bussaratid V, Koonsaeng S. Knowledge, attitudes, and acceptability of a human papillomavirus vaccine among healthcare providers. Southeast Asian J Trop Med Public Health. 2009;40(5):1048-56.
34. Weiss TW, Zimet GD, Rosenthal SL, Brenneman SK, Klein JD. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females. J Adolesc Health. 2010;47(1):3-11. doi:10.1016/j.jadohealth. 2010.03.003.
35. Javanbakht M, Stahlman S, Walker S, Gottlieb S, Markowitz L, Liddon N, et al. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community. Vaccine. 2012;30(30): 4511-6.
36. Cranley L, Doran DM, Tourangeau AE, Kushniruk A, Nagle L. Nurses' uncertainty in decision-making: a literature review. Worldviews Evid Based Nurs. 2009;6(1):3-15. doi:10.1111/j.1741-6787.2008.00138.x.
37. O'Riordan M, Aktürk Z, Ortiz JMB, Daǧdeviren N, Elwyn G, Micallef A, et al. Dealing with uncertainty in general practice: an essential skill for the general practitioner. Qual Prim Care. 2011;19(3):175-81.
38. Shapiro J, Astin J, Shapiro SL, Robitshek D, Shapiro DH. Coping with loss of control in the practice of medicine. Fam Syst Health. 2011;29(1):15-28. doi:10.1037/a0022921.
39. Breaden K, Hegarty M, Swetenham K, Grbich C. Negotiating uncertain terrain: a qualitative analysis of clinicians' experiences of refractory suffering. J Palliat Med. 2012;15(8):896-901. doi:10.1089/jpm.2011.0442.
40. Holmes S, Ponte M. En-case-ing the patient: disciplining uncertainty in medical student patient presentations. Cult Med Psychiatry. 2011;35(2):163-82. doi:10.1007/s11013-011-9213-3.
41. Nevalainen MK, Mantyranta T, Pitkala KH. Facing uncertainty as a medical student - a qualitative study of their reflective learning diaries and writings on specific themes during the first clinical year. Patient Educ Couns. 2010;78(2):218-23. doi:10.1016/j.pec.2009.07.011.
42. Riessman CK. Performing identities in illness narrative: masculinity and multiple sclerosis. Qual Res. 2003;3(1):5-33.
43. Stephens C. Narrative analysis in health psychology research: personal, dialogical and social stories of health. Health Psychol Rev. 2011;5(1):62-78.
44. Lupton D. The imperative of health: Public health and the regulated body. Thousand Oaks: Sage; 1995.
45. Gold K. Reading (and writing) between the lines: Narrative as relational resource for alternative stories of health care practice. Tilburg: Tilburg University; 2013.
46. Todorova I, Baban A, Balbanova D, Panayotova Y, Bradley J. Providers' construction of women's role in cervical cancer screening in Eastern Europe. Soc Sci Med. 2006;63(3):776-87. (Pubitemid 43831426)
47. Todorova I. Preventing cancer inmen and women: Current advances, disparities, contexts and examples from HPV related cancers. Key Note Lecture. 13th International Congress of Behavioral Medicine; Budapest, Hungary2012.